Role of vildagliptin in managing type 2 diabetes mellitus in the elderly

Author： Halimi S.   Raccah D.   Schweizer A.   Dejager S.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.26, Iss.7, 2010-07, pp. : 1647-1656

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment adherence with vildagliptin compared to sulphonylurea as add-on to metformin in Muslim patients with type 2 diabetes mellitus fasting during Ramadan

By Hanif W.  

Current Medical Research and Opinion, Vol. 29, Iss. 7, 2013-07 ,pp. : 807-811

Informa Healthcare

Access to resources Recommend Favorite

Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany

By Göke R.   Gruenberger J. B.   Bader G.   Dworak M.  

Current Medical Research and Opinion, Vol. 30, Iss. 5, 2014-05 ,pp. : 785-789

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness of vildagliptin as add‐on to metformin monotherapy among uncontrolled type 2 diabetes mellitus patients in a real‐world setting

By  

JOURNAL OF DIABETES, Vol. 10, Iss. 1, 2018-01 ,pp. : 68-72

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vildagliptin add‐on to SU in China

By  

JOURNAL OF DIABETES, Vol. 7, Iss. 2, 2015-03 ,pp. : 174-181

John Wiley & Sons Inc

Access to resources Recommend Favorite

Study of the pharmacokinetic interaction of vildagliptin and metformin in patients with type 2 diabetes*

By He Yan-Ling   Sabo Ron   Picard Franck   Wang Yibin   Herron Jerry   Ligueros-Saylan Monica   Dole William P.  

Current Medical Research and Opinion, Vol. 25, Iss. 5, 2009-05 ,pp. : 1265-1272

Informa Healthcare

Access to resources Recommend Favorite